Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer’s disease
Frölich, Lutz; Wunderlich, Glen; Thamer, Claus; Roehrle, Michael; Garcia, Miguel; Dubois, Bruno
- 期刊名称Alzheimer's Research & Therapy
- 作者Frölich, Lutz; Wunderlich, Glen; Thamer, Claus; Roehrle, Michael; Garcia, Miguel; Dubois, Bruno
- 卷第11卷
- 期第1期
- 电子ISSN1758-9193
- 文件大小840.38KB
- 发表时间2019-12
- DOI10.1186/s13195-019-0467-2